Literature DB >> 19249312

Crystal structures of wild-type and mutant methicillin-resistant Staphylococcus aureus dihydrofolate reductase reveal an alternate conformation of NADPH that may be linked to trimethoprim resistance.

Kathleen M Frey1, Jieying Liu, Michael N Lombardo, David B Bolstad, Dennis L Wright, Amy C Anderson.   

Abstract

Both hospital- and community-acquired Staphylococcus aureus infections have become major health concerns in terms of morbidity, suffering and cost. Trimethoprim-sulfamethoxazole (TMP-SMZ) is an alternative treatment for methicillin-resistant S. aureus (MRSA) infections. However, TMP-resistant strains have arisen with point mutations in dihydrofolate reductase (DHFR), the target for TMP. A single point mutation, F98Y, has been shown biochemically to confer the majority of this resistance to TMP. Using a structure-based approach, we have designed a series of novel propargyl-linked DHFR inhibitors that are active against several trimethoprim-resistant enzymes. We screened this series against wild-type and mutant (F98Y) S. aureus DHFR and found that several are active against both enzymes and specifically that the meta-biphenyl class of these inhibitors is the most potent. In order to understand the structural basis of this potency, we determined eight high-resolution crystal structures: four each of the wild-type and mutant DHFR enzymes bound to various propargyl-linked DHFR inhibitors. In addition to explaining the structure-activity relationships, several of the structures reveal a novel conformation for the cofactor, NADPH. In this new conformation that is predominantly associated with the mutant enzyme, the nicotinamide ring is displaced from its conserved location and three water molecules complete a network of hydrogen bonds between the nicotinamide ring and the protein. In this new position, NADPH has reduced interactions with the inhibitor. An equilibrium between the two conformations of NADPH, implied by their occupancies in the eight crystal structures, is influenced both by the ligand and the F98Y mutation. The mutation induced equilibrium between two NADPH-binding conformations may contribute to decrease TMP binding and thus may be responsible for TMP resistance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19249312      PMCID: PMC2723953          DOI: 10.1016/j.jmb.2009.02.045

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  19 in total

1.  National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

Authors: 
Journal:  Am J Infect Control       Date:  2004-12       Impact factor: 2.918

Review 2.  Community-acquired methicillin-resistant Staphylococcus aureus: current perspectives.

Authors:  M F Q Kluytmans-Vandenbergh; J A J W Kluytmans
Journal:  Clin Microbiol Infect       Date:  2006-03       Impact factor: 8.067

3.  Structure-guided development of efficacious antifungal agents targeting Candida glabrata dihydrofolate reductase.

Authors:  Jieying Liu; David B Bolstad; Adrienne E Smith; Nigel D Priestley; Dennis L Wright; Amy C Anderson
Journal:  Chem Biol       Date:  2008-09-22

4.  A single amino acid substitution in Staphylococcus aureus dihydrofolate reductase determines trimethoprim resistance.

Authors:  G E Dale; C Broger; A D'Arcy; P G Hartman; R DeHoogt; S Jolidon; I Kompis; A M Labhardt; H Langen; H Locher; M G Page; D Stüber; R L Then; B Wipf; C Oefner
Journal:  J Mol Biol       Date:  1997-02-14       Impact factor: 5.469

5.  Highly efficient ligands for dihydrofolate reductase from Cryptosporidium hominis and Toxoplasma gondii inspired by structural analysis.

Authors:  Phillip M Pelphrey; Veljko M Popov; Tammy M Joska; Jennifer M Beierlein; Erin S D Bolstad; Yale A Fillingham; Dennis L Wright; Amy C Anderson
Journal:  J Med Chem       Date:  2007-02-02       Impact factor: 7.446

Review 6.  Basis of selectivity of antibacterial diaminopyrimidines.

Authors:  D P Baccanari; L F Kuyper
Journal:  J Chemother       Date:  1993-12       Impact factor: 1.714

7.  Probing the active site of Candida glabrata dihydrofolate reductase with high resolution crystal structures and the synthesis of new inhibitors.

Authors:  Jieying Liu; David B Bolstad; Adrienne E Smith; Nigel D Priestley; Dennis L Wright; Amy C Anderson
Journal:  Chem Biol Drug Des       Date:  2009-01       Impact factor: 2.817

8.  Binding of coenzyme analogues to Lactobacillus casei dihydrofolate reductase: binary and ternary complexes.

Authors:  B Birdsall; A S Burgen; G C Roberts
Journal:  Biochemistry       Date:  1980-08-05       Impact factor: 3.162

9.  Synthetic and crystallographic studies of a new inhibitor series targeting Bacillus anthracis dihydrofolate reductase.

Authors:  Jennifer M Beierlein; Kathleen M Frey; David B Bolstad; Phillip M Pelphrey; Tammy M Joska; Adrienne E Smith; Nigel D Priestley; Dennis L Wright; Amy C Anderson
Journal:  J Med Chem       Date:  2008-12-11       Impact factor: 7.446

10.  Solution structure of human dihydrofolate reductase in its complex with trimethoprim and NADPH.

Authors:  Nadezhda V Kovalevskaya; Yegor D Smurnyy; Vladimir I Polshakov; Berry Birdsall; Alan F Bradbury; Tom Frenkiel; James Feeney
Journal:  J Biomol NMR       Date:  2005-09       Impact factor: 2.835

View more
  30 in total

1.  Predicting resistance mutations using protein design algorithms.

Authors:  Kathleen M Frey; Ivelin Georgiev; Bruce R Donald; Amy C Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-19       Impact factor: 11.205

Review 2.  Antibacterial Antifolates: From Development through Resistance to the Next Generation.

Authors:  Alexavier Estrada; Dennis L Wright; Amy C Anderson
Journal:  Cold Spring Harb Perspect Med       Date:  2016-08-01       Impact factor: 6.915

3.  Protein design algorithms predict viable resistance to an experimental antifolate.

Authors:  Stephanie M Reeve; Pablo Gainza; Kathleen M Frey; Ivelin Georgiev; Bruce R Donald; Amy C Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-31       Impact factor: 11.205

4.  Coarse-grain simulations on NMR conformational ensembles highlight functional residues in proteins.

Authors:  Sophie Sacquin-Mora
Journal:  J R Soc Interface       Date:  2019-07-10       Impact factor: 4.118

5.  Crystallization and preliminary X-ray analysis of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase from Staphylococcus aureus.

Authors:  Sandeep Chhabra; Janet Newman; Thomas S Peat; Ross T Fernley; Joanne Caine; Jamie S Simpson; James D Swarbrick
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-04-30

6.  Acetylenic linkers in lead compounds: a study of the stability of the propargyl-linked antifolates.

Authors:  Wangda Zhou; Kishore Viswanathan; Dennis Hill; Amy C Anderson; Dennis L Wright
Journal:  Drug Metab Dispos       Date:  2012-07-18       Impact factor: 3.922

Review 7.  Antifolate agents: a patent review (2006 - 2010).

Authors:  Dennis L Wright; Amy C Anderson
Journal:  Expert Opin Ther Pat       Date:  2011-05-27       Impact factor: 6.674

Review 8.  Winning the arms race by improving drug discovery against mutating targets.

Authors:  Amy C Anderson
Journal:  ACS Chem Biol       Date:  2011-11-11       Impact factor: 5.100

9.  Elucidating features that drive the design of selective antifolates using crystal structures of human dihydrofolate reductase.

Authors:  Kristen M Lamb; Narendran G-Dayanandan; Dennis L Wright; Amy C Anderson
Journal:  Biochemistry       Date:  2013-10-03       Impact factor: 3.162

10.  Kinetic and structural characterization of dihydrofolate reductase from Streptococcus pneumoniae.

Authors:  Jeeyeon Lee; Neela H Yennawar; Jongsik Gam; Stephen J Benkovic
Journal:  Biochemistry       Date:  2010-01-12       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.